Woodline Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.31M | Sell |
|
|||||
|
2025
Q2 | $7.26M | Buy |
|
|||||
|
2025
Q1 | $4.64M | Buy |
|
|||||
|
2024
Q4 | $4M | Buy |
|
|||||
|
2024
Q3 | $4.7M | Sell |
|
|||||
|
2024
Q2 | $6.85M | Sell |
|
|||||
|
2024
Q1 | $11.1M | Buy |
|
|||||
|
2023
Q4 | $3.13M | Sell |
|
|||||
|
2023
Q3 | $4.56M | Buy |
|
|||||
|
2023
Q2 | $2.81M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $11.9M | Buy |
|
|||||
|
2021
Q4 | $710K | Buy |
|